Бесплатная главастраницы PDF 9–25

1. Анатомия и патогенез склерита

В оригинале: 1: Anatomy and Pathogenesis of Scleritis

Из книги «Склерит». Перевод главы на русский открыт всем без входа и подписки.

Содержание главы
  1. 1. Анатомия и патогенез склерита
  2. Введение
  3. Анатомия склеры
  4. Кровоснабжение
  5. Маркёры эписклеральных сосудов
  6. Клеточный состав склеры
  7. Биохимический состав склеры человека
  8. Классификация склерита
  9. Патогенез
  10. Является ли склерит локальным глазным васкулитом?
  11. Механизмы разрушения тканей при склерите
  12. Боль при склерите
  13. Животные модели склерита
  14. Перспективы
  15. Литература
  1. 31. Rao NA, Marak GE, Hidayat AA. Necrotizing scleritis. A clinico-pathologic study of 41 cases. Ophthalmology. 1985;92(11):1542–9.
  2. 32. Usui Y, Parikh J, Goto H, Rao NA. Immunopathology of necrotising scleritis. Br J Ophthalmol. 2008;92(3):417–9.
  3. 33. Watson PG. Anterior segment fluorescein angiography in the surgery of immunologically induced corneal and scleral destructive disorders. Ophthalmology. 1987;94(11):1452–64.
  4. 34. Fong LP, Sainz de la Maza M, Rice BA, Kupferman AE, Foster CS. Immunopathology of scleritis. Ophthalmology. 1991;98(4):472–9.
  5. 35. Sangwan VS, Merchant A, Sainz de la Maza M, Foster CS. Leukocyte adhesion molecule expression in scleritis. Arch Ophthalmol. 1998;116(11):1476–80.
  6. 36. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–108.
  7. 37. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–19.
  8. 38. Akhavani MA, Madden L, Buysschaert I, Sivakumar B, Kang N, Paleolog EM. Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis. Arthritis Res Ther. 2009;11(3):R64.
  9. 39. McInnes IB, O’Dell JR. State-of-the-art: rheumatoid arthritis. Ann Rheum Dis. 2010;69(11):1898–906.
  10. 40. Craft JE. Dissecting the immune cell mayhem that drives lupus pathogenesis. Sci Transl Med. 2011;3(73):73ps79.
  11. 41. Elkon KB, Stone VV. Type I interferon and systemic lupus erythematosus. J Interf Cytokine Res. 2011;31(11):803–12.
  12. 42. Kaplan MJ. Neutrophils in the pathogenesis and manifestations of SLE. Nat Rev Rheumatol. 2011;7(12):691–9.
  13. 43. Warde N. Autoimmunity: the role of neutrophils in SLE: untangling the NET. Nat Rev Rheumatol. 2011;7(5):252.
  14. 44. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med. 2011;3(73):73ra20.
  15. 45. Jennette JC, Falk RJ, Gasim AH. Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Curr Opin Nephrol Hypertens. 2011;20(3):263–70.
  16. 46. Harper L, Cockwell P, Adu D, Savage CO. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int. 2001;59(5):1729–38.
  17. 47. Brouwer E, Huitema MG, Mulder AH, Heeringa P, van Goor H, Tervaert JW, Weening JJ, Kallenberg CG. Neutrophil activation in vitro and in vivo in Wegener’s granulomatosis. Kidney Int. 1994;45(4):1120–31.
  18. 48. Hu N, Westra J, Kallenberg CG. Dysregulated neutrophil–endothelial interaction in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides: implications for pathogenesis and disease intervention. Autoimmun Rev. 2011;10(9):536–43.
  19. 49. Muller Kobold AC, Kallenberg CG, Tervaert JW. Monocyte activation in patients with Wegener’s granulomatosis. Ann Rheum Dis. 1999;58(4):237–45.
  20. 50. Hoang LT, Lim LL, Vaillant B, Choi D, Rosenbaum JT. Antineutrophil cytoplasmic antibody-associated active scleritis. Arch Ophthalmol. 2008;126(5):651–5.
  21. 51. Bansal PJ, Tobin MC. Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2004;93(4):398–401.
  22. 52. Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010;363(3):211–20.
  23. 53. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221–32.